semaglutide and asthma Proteomic changes upon treatment with semaglutide in individuals with obesity RACGP - Evidence 'growing' for
Description
The evidence supporting CGM is already overwhelming
It's crucial to understand that GLP-1 is not a magic pill, but should be combined with a balanced diet and regular exercise
Never exceed conservative dosing: Doses above 5060 mcg/day lack robust clinical research support and may substantially increase adverse effect risk [2]
If calcitonin exceeds 50 ng/L (50 pg/mL), further diagnostic workup for MTC is warranted, including thyroid ultrasound and potentially fine-needle aspiration biopsy
The safety profile was similar to other incretin-based therapies
For example, Zhang et al
